Valuentum Exclusive Analysis for the Discerning Investor

Symbol Keyword

Member Login Email Password Join Now Forgotten Password Newsletters/Portfolios View Current and Archived Dividend Growth Newsletters View Current and Archived Best Ideas Newsletters Valuentum's Dividend Growth Newsletter Portfolio Valuentum's Best Ideas Newsletter Portfolio Order the Exclusive Publication! View Current and Archived Exclusive Editions Order the High Yield Dividend Newsletter! Dividend Cushion Efficacy Calculation Dividend-Adjusted Leverage White Paper Stock Screens How to Filter Data in Microsoft Excel Like a Pro Download Weekly Stock Screener (xls) -- login required The Quarterly DataScreener Products & Tools Financial Advisor (GOLD LEVEL) Publications DCF Valuation Model Template Order Value Trap Order Value Trap, second edition Value Trap Order PDF Copy Order Paperback Copy Presentation BookLife Review BlueInk Review Foreword Review Readers' Favorite Review Axiom Bronze Praise The Buying Index, VBI Value and Momentum Within Stocks, Too (2017) The Case for the Valuentum Style of Investing (2012) Investing's Odd Couple: Value and Momentum (2013) Stock-Selection Methodology, the Valuentum Buying Index (2011) Why Valuentum Buying Index Ratings Matter (2014) Dividend Changes Dividend Increases/Decreases for the Week of April 5 Dividend Increases/Decreases for the Week of March 29 Dividend Increases/Decreases for the Week of March 22 Dividend Increases/Decreases for the Week of March 15 Dividend Increases/Decreases for the Week of March 8

Results 101 - 110 of 201 for hum. (0.31 seconds) Valuentum Weekly Web Commentary Let’s take a look at some of the Valuentum... Loxo Oncology Presents Compelling Data on Its TRK Inhibitors Image Source: Loxo Oncology. The field of oncology... Which Mid-Stage Biotech Can Grow Into the Next Large Cap Biotech Behemoth? Image Source: Steven Depolo. The biotech field is on... Dividend Growth Newsletter REITs Renewed speculation over what the Fed will do next with... Omega Healthcare and Holly Energy Partners: Case Studies in REIT and MLP Income Evaluation Image shown: The performance of the Vanguard REIT ETF... Is the Worst Behind Us? Not Likely What a hectic month. The 20 Something’s Stock Portfolio Let’s have some fun. There’s nothing dull... Trouble Ahead for Sempra Energy? Sempra Energy continues to take heat over a developing... Novartis Is Building a Significant Cardiovascular Franchise Image shown: The performance of Novartis since the... How the FDA’s Delay of Baricitinib Impacts Eli Lilly and Incyte Image Source: Paul Sableman. The FDA dealt Eli Lilly and... prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | next